The Arzneimittelmarkt-Neuordnungsgesetz (AMNOG, English translation: "Pharmaceuticals Market Reorganisation Act") is a German law relating to the marketing of
pharmaceutical
A medication (also called medicament, medicine, pharmaceutical drug, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy ( pharmacotherapy) is an important part of the medical field and ...
products in
Germany
Germany, officially the Federal Republic of Germany (FRG),, is a country in Central Europe. It is the most populous member state of the European Union. Germany lies between the Baltic and North Sea to the north and the Alps to the sou ...
. It requires drug manufacturers to submit evidence to the
Federal Joint Committee (Germany) The Federal Joint Committee (German: ''Gemeinsamer Bundesausschuss'') refers to a group of German public health agencies that were merged in 2004, under an independent chairman. It is authorized to make binding regulations growing out of health ref ...
that shows whether their new products have an added benefit compared to previous products. It is credited with reducing the cost of healthcare in Germany.
References
See also
*
Healthcare in Germany
Germany has a universal multi-payer health care system paid for by a combination of statutory health insurance (') and private health insurance (').
The turnover of the health sector was about US$368.78 billion (€287.3 billion) in 2010, equi ...
*
Institute for Quality and Efficiency in Health Care
The Institute for Quality and Efficiency in Healthcare (IQWiG) (german: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen) is a German agency responsible for assessing the quality and efficiency of medical treatments, including dr ...
Health law in Germany
Pharmaceutical industry
{{Germany-law-stub